Label: MUCUS RELIEF 600 MG- guaifenesin tablet, extended release
MUCUS RELIEF MAXIMUM STRENGTH 1200 MG- guaifenesin tablet, extended release

  • NDC Code(s): 53041-190-16, 53041-190-20, 53041-190-32, 53041-190-38, view more
    53041-191-37, 53041-191-48, 53041-191-58, 53041-191-62
  • Packager: Guardian Drug Company
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 30, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT(in each extended-release tablet)

    Guaifenesin 1200 mg

  • PURPOSE

    Expectorant

  • USE(S)

    helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

  • WARNING

    .

  • DO NOT USE

    for children under 12 years of age

  • ASK A DOCTOR BEFORE USE IF YOU HAVE

    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • cough accompanied by too much phlegm (mucus)
  • STOP USE AND A ASK DOCTOR IF

    • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
  • IF PREGNANT OR BREAST-FEEDING,

    ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • DIRECTIONS

    • do not crush, chew, or break tablet
    • take with a full glass of water
    • this product can be administered without regard for the timing of meals
    • adults and children 12 years of age and over: 1 tablet every 12 hours.  
    • Do not exceed 2 tablets in 24 hours.
    • children under 12 years of age: do not use
  • OTHER INFORMATION

    • tamper evident: do not use if carton is open or if printed seal on blister is broken or missing
    • store between 20 to 25°C (68 to 77°F)
  • INACTIVE INGREDIENTS

    carbomer homopolymer, hypromellose, microcrystalline cellulose, povidone

  • QUESTIONS

    1-609-860-2600

    Hours: 8am - 4pm, EST

    You may also report side effects to this phone number. 

  • PRINCIPAL DISPLAY PANEL

    NDC 53041-191-58

    Compare to the active ingredient in Mucinex® Maximum Strength Extended Release 1200 mg Tablets

    GUARDIAN

    12 HOUR

    MAXIMUM STRENGTH

    Mucus Relief

    Guaifenesin Extended-Release Tablets 1200 mg

    Expectorant

    Relieves Chest Congestion

    Thins and Loosens Mucus

    14 EXTENDED-RELEASE TABLETS

    23414

    NDC 53041-191-48

    GUARDIAN

    12 HOUR

    MAXIMUM STRENGTH

    Mucus Relief

    Guaifenesin Extended-Release Tablets 1200 mg

    Expectorant

    Relieves Chest Congestion

    Thins and Loosens Mucus

    28 EXTENDED-RELEASE TABLETS


    23428


  • ACTIVE INGREDIENT (in each extended- release tablet)

    Guaifenesin 600 mg

  • PURPOSE

    Expectorant

  • USE(S)

    helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

  • WARNING

    .

  • DO NOT USE

    • for children under 12 years of age
  • ASK A DOCTOR BEFORE USE IF YOU HAVE

    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • cough accompanied by too much phlegm (mucus)
  • STOP USE AND ASK A DOCTOR IF

    • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
  • IF PREGNANT OR BREAST-FEEDING,

    ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • DIRECTIONS

    • do not crush, chew, or break tablet
    • take with a full glass of water
    • this product can be administered without regard for the timing of meals
    • adults and children 12 years of age and over: 1 or 2 tablets every 12 hours.  
    • Do not exceed 4 tablets in 24 hours.
    • children under 12 years of age: do not use
  • OTHER INFORMATION

    • tamper evident: do not use if carton is open or if printed seal on blister is broken or missing
    • store between 20 to 25°C (68 to 77°F)
  • INACTIVE INGREDIENTS

    carbomer homopolymer, hypromellose, microcrystalline cellulose, povidone

  • QUESTIONS?

    1-609-860-2600

    Hours: 8am - 4pm, EST

    You may also report side effects to this phone number. 

  • PRINCIPAL DISPLAY PANEL

    NDC 53041-190-32

    Compare to the active ingredient in Mucinex® Extended Release 600 mg Tablets

    GUARDIAN

    12 HOUR

    Mucus Relief

    Guaifenesin Extended-Release Tablets 1200 mg

    Expectorant

    Relieves Chest Congestion

    Thins and Loosens Mucus

    20 EXTENDED-RELEASE TABLETS


    23320


    NDC 53041-190-20

    GUARDIAN

    12 HOUR

    Mucus Relief

    Guaifenesin Extended-Release Tablets 1200 mg

    Expectorant

    Relieves Chest Congestion

    Thins and Loosens Mucus

    500 EXTENDED-RELEASE TABLETS

    233500


  • INGREDIENTS AND APPEARANCE
    MUCUS RELIEF 600 MG 
    guaifenesin tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53041-190
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN600 mg
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POVIDONE K90 (UNII: RDH86HJV5Z)  
    Product Characteristics
    ColorWHITEScoreno score
    ShapeCAPSULESize17mm
    FlavorImprint Code G233
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53041-190-322 in 1 CARTON06/24/2020
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:53041-190-384 in 1 CARTON06/24/2020
    210 in 1 BLISTER PACK; Type 0: Not a Combination Product
    3NDC:53041-190-16100 in 1 BOTTLE; Type 0: Not a Combination Product06/24/2020
    4NDC:53041-190-20500 in 1 BOTTLE; Type 0: Not a Combination Product06/24/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20921506/24/2020
    MUCUS RELIEF MAXIMUM STRENGTH 1200 MG 
    guaifenesin tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53041-191
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POVIDONE K90 (UNII: RDH86HJV5Z)  
    Product Characteristics
    ColorWHITEScoreno score
    ShapeCAPSULESize22mm
    FlavorImprint Code G234
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53041-191-582 in 1 CARTON06/24/2020
    17 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:53041-191-484 in 1 CARTON06/24/2020
    27 in 1 BLISTER PACK; Type 0: Not a Combination Product
    3NDC:53041-191-3728 in 1 BOTTLE; Type 0: Not a Combination Product04/30/2024
    4NDC:53041-191-6270 in 1 BOTTLE; Type 0: Not a Combination Product04/30/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20921506/24/2020
    Labeler - Guardian Drug Company (119210276)
    Establishment
    NameAddressID/FEIBusiness Operations
    Guardian Drug Company119210276MANUFACTURE(53041-190, 53041-191)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!